Jun 22, 2026 07:09AM
Jun 22, 2026 07:01AM
Jun 22, 2026 07:00AM
Apr 29, 2026 08:09AM
Apr 29, 2026 07:48AM
Apr 29, 2026 07:47AM
Apr 29, 2026 12:00AM AbbVie Q1 earnings preview: analysts eye immunology growth trends
Apr 10, 2026 06:57AM
Mar 31, 2026 08:00AM
Feb 20, 2026 07:58AM
Feb 4, 2026 08:04AM
Feb 4, 2026 07:51AM
Feb 4, 2026 07:48AM
Feb 3, 2026 06:00PM AbbVie earnings preview: Bernstein expects another tightly framed outlook
Jan 28, 2026 06:57AM
Jan 21, 2026 10:00AM
Jan 12, 2026 06:00AM
Jan 12, 2026 06:00AM
Jan 9, 2026 07:46AM
Jan 7, 2026 04:12PM
Jan 7, 2026 08:00AM AbbVie to Host Full-Year and Fourth-Quarter 2025 Earnings Conference Call
Dec 10, 2025 08:20AM
Dec 10, 2025 02:04AM
Nov 4, 2025 08:14AM
Oct 31, 2025 08:04AM
Oct 31, 2025 07:50AM
Oct 31, 2025 07:49AM
Oct 31, 2025 06:00AM Analysts expect AbbVie’s core franchises to offset R&D costs ahead of Q3 earnings
Oct 20, 2025 08:05AM
Oct 20, 2025 07:22AM
Oct 13, 2025 04:03PM
Oct 3, 2025 04:10PM
Oct 2, 2025 08:00AM
Aug 11, 2025 06:00PM
Aug 5, 2025 06:43AM Bernstein Reiterates Market Perform Rating on Abbvie (ABBV)
Jul 31, 2025 08:09AM
Jul 31, 2025 07:44AM
Jul 31, 2025 12:00AM
Jul 10, 2025 06:51AM
Jul 3, 2025 01:11PM
Jun 30, 2025 08:00AM
May 14, 2025 09:26AM AbbVie, Merck cut to Neutral at Citi
Apr 29, 2025 07:40AM
Apr 28, 2025 11:34AM
Apr 25, 2025 11:08AM
Apr 25, 2025 07:57AM
Apr 25, 2025 07:43AM
Apr 25, 2025 04:00AM
Apr 8, 2025 08:43AM Goldman turns cautious on major pharma names, sees select upside at Eli Lilly
Apr 3, 2025 04:34PM

1,200,324 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All